Results 131 to 140 of about 418,673 (161)

Efficacy and safety of switching to insulin glargine 300 U/mL in people with type 2 diabetes uncontrolled on basal insulin in China: A post hoc subpopulation analysis of the INITIATION study. [PDF]

Diabetes Obes Metab
Chen L, Wan H, Han J, Yang C, Shao H, Li J, Yan W, Xiao J, Sun Y, Li M, Han Y, Kang L, Zhang M.   +12 more
europepmc   +1 more source

Retrospective Analysis of Once-Daily Versus Twice-Daily Insulin Glargine Dosing in Noncritically Ill Individuals. [PDF]

Diabetes Spectr
Hogue D, Clements J, Wright A.
europepmc   +1 more source

Correction to "Effects of Insulin Glargine U300 Versus Insulin Degludec U100 on Glycemic Variability, Hypoglycemia, and Diet Evaluated by Continuous Glucose Monitoring in Type 1 Diabetes: A Retrospective Cross-Sectional Study". [PDF]

Kaohsiung J Med Sci
europepmc   +1 more source

5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine. [PDF]

Diabetes Obes Metab
Niu S, Alkhuzam KA, Guan D, Jiao T, Shi L, Fonseca V, Laiteerapong N, Ali MK, Schatz DA, Guo J, Shao H.   +10 more
europepmc   +1 more source

Multicenter, Phase 4 Clinical Study from India to Evaluate the Safety and Efficacy of Insulin Glargine 300 U/ml in Insulin-Naïve People with Type 2 Diabetes Uncontrolled on Oral Anti-hyperglycemic Drugs: SAFEGUARD Study. [PDF]

Diabetes Ther
Mohan V, Sethi B, Jain SM, Sahay R, Ramanathan B, Murthy S, Singh KP, Menon S, Gadekar A, Salvi V, Gandhi K.   +10 more
europepmc   +1 more source

Effects of insulin glargine U300 versus insulin degludec U100 on glycemic variability, hypoglycemia, and diet evaluated by continuous glucose monitoring in type 1 diabetes: a retrospective cross-sectional study. [PDF]

Kaohsiung J Med Sci
Tsai PL, Lin CH, Huang YY, Chen HY, Lin YH.   +4 more
europepmc   +1 more source

Frequency and Severity of Hypoglycemia Under Conditions of Increased Hypoglycemic Risk with Insulin Efsitora Alfa Versus Insulin Glargine Treatment in Participants with Type 2 Diabetes. [PDF]

Diabetes Ther
Heise T, Andersen G, Pratt EJ, Leohr J, Fukuda T, Wang Q, Kazda C, Bue-Valleskey JM, Bergenstal RM.   +8 more
europepmc   +1 more source

Real-Life Effectiveness of iGlarLixi (Insulin Glargine 100 U/ml and Lixisenatide) in People with Type 2 Diabetes (T2D) According to Baseline HbA1c and BMI. [PDF]

Diabetes Ther
Kis JT, Seufert J, Haluzík M, Bonnemaire M, Vera C, Tournay M, Freemantle N, Guja C.   +7 more
europepmc   +1 more source

AUGMENTed Real-World Data Enhances Comparative Efficacy Between Once-Weekly Insulin Icodec with Dosing Guide App Versus Once-Daily Insulin Glargine U300 in Insulin-Naive Type 2 Diabetes. [PDF]

Diabetes Ther
Billings LK, Asong M, Bøg M, Clancy S, Kruse C, de Laguiche E, Maddaloni E.   +6 more
europepmc   +1 more source

A randomized, multicentre trial of insulin glargine versus NPH insulin in people with Type 1 diabetes

Home P, European Insulin Glargine Study Gr   +1 more
core   +2 more sources